Inhibition of apoptotic signaling and neointimal hyperplasia by tempol and nitric oxide synthase following vascular injury

J Vasc Res. 2009;46(2):109-18. doi: 10.1159/000151444. Epub 2008 Aug 20.

Abstract

Objectives: We hypothesized that redox-mediated apoptosis of medial smooth muscle cells (SMC) during the acute phase of vascular injury contributes to the pathophysiology of vascular disease.

Methods: Apoptosis of medial SMC (1-14 days following balloon injury) was identified in rat carotid arteries by in situ DNA labeling. NADPH-derived superoxide and expression of Bcl-xL, Bax, caspase-3 and caspase-9 were assessed. The antioxidant tempol was administered in drinking water throughout the experimental period, and local adenoviral-mediated gene transfer of eNOS was performed prior to vascular injury.

Results: Balloon injury increased NADPH-dependent superoxide production, medial SMC apoptosis, Bax-positive medial SMC index, Bax/Bcl-xL ratio, and caspase-3 and caspase-9 expression in the injured arteries. Treatment with tempol or eNOS gene transfer decreased superoxide levels and medial SMC apoptosis, with a concomitant increase in medial SMC density. Inhibition of superoxide was associated with a decreased Bax/Bcl-xL ratio, and caspase-3 and -9 expression. Tempol treatment and eNOS gene therapy significantly reduced neointima formation.

Conclusion: Vascular generation of reactive oxygen species participates in Bax activation and medial SMC apoptosis. These effects likely contribute to the shedding of cell-cell adhesion molecules and promote medial SMC migration and proliferation responsible for neointimal hyperplasia.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adenoviridae / genetics
  • Animals
  • Antioxidants / pharmacology*
  • Apoptosis / drug effects*
  • Carotid Artery Injuries / enzymology
  • Carotid Artery Injuries / genetics
  • Carotid Artery Injuries / pathology
  • Carotid Artery Injuries / therapy*
  • Carotid Artery, Common / drug effects*
  • Carotid Artery, Common / enzymology
  • Carotid Artery, Common / pathology
  • Caspase 3 / metabolism
  • Caspase 9 / metabolism
  • Cyclic N-Oxides / pharmacology*
  • Disease Models, Animal
  • Gene Transfer Techniques
  • Genetic Therapy*
  • Genetic Vectors
  • Hyperplasia
  • Male
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / enzymology
  • Muscle, Smooth, Vascular / pathology
  • Nitric Oxide Synthase Type III / biosynthesis*
  • Nitric Oxide Synthase Type III / genetics
  • Oxidative Stress / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / drug effects
  • Spin Labels
  • Superoxides / metabolism
  • Time Factors
  • Tunica Intima / drug effects*
  • Tunica Intima / enzymology
  • Tunica Intima / pathology
  • bcl-2-Associated X Protein / metabolism
  • bcl-X Protein / metabolism

Substances

  • Antioxidants
  • Bax protein, rat
  • Bcl2l1 protein, rat
  • Cyclic N-Oxides
  • Spin Labels
  • bcl-2-Associated X Protein
  • bcl-X Protein
  • Superoxides
  • Nitric Oxide Synthase Type III
  • Casp3 protein, rat
  • Casp9 protein, rat
  • Caspase 3
  • Caspase 9
  • tempol